Epirium Bio Patents – Insights & Stats (Updated 2023)

Epirium Bio has a total of 41 patents globally, out of which 13 have been granted. Of these 41 patents, more than 73% patents are active. United States of America is where Epirium Bio has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Epirium Bio.

Epirium Bio was founded in the year 2017. The Company is a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease.

Do read about some of the most popular patents of Epirium Bio which have been covered by us in this article and also you can find Epirium Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Epirium Bio patent portfolio.

How many patents does Epirium Bio have?

Epirium Bio has a total of 41 patents globally. These patents belong to 18 unique patent families. Out of 41 patents, 30 patents are active.

How Many Patents did Epirium Bio File Every Year?

Epirium Bio Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEpirium Bio Applications FiledEpirium Bio Patents Granted
202311
202261
202154
202031
201912
201813
201721
20161
201511
20146
20131
20123

How many Epirium Bio patents are Alive/Dead?

Epirium Bio Patent Portfolio

 How Many Patents did Epirium Bio File in Different Countries?

Epirium Bio Worldwide Patent Filing

Countries in which Epirium Bio Filed Patents

CountryPatents
United States Of America18
Europe4
Australia3
Canada3
Brazil2
Israel2
China2
Austria1
Germany1
Argentina1
Taiwan1

Where are Research Centres of Epirium Bio Patents Located?

R&D Centers of Epirium Bio

 10 Best Epirium Bio Patents

US20150376225A1 is the most popular patent in the Epirium Bio portfolio. It has received 18 citations so far from companies like Sage Therapeutics, Inc., Aska Pharmaceutial Co., Ltd. and Hunan Huacheng Biological Resources Co., Ltd.

Below is the list of 10 most cited patents of Epirium Bio:

Publication NumberCitation Count
US20150376225A118
US9901564B24
US10052316B23
US20190262347A13
US10898465B22
WO2022082009A12
US11273144B21
US10618933B21
US9556140B21
US9428482B21

What Percentage of Epirium Bio US Patent Applications were Granted?

Epirium Bio (Excluding its subsidiaries) has filed 16 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 73.33%.

Below are the key stats of Epirium Bio patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Epirium Bio?

Law FirmTotal ApplicationsSuccess Rate
Morrison & Foerster Llp1476.92%
Foley Hoag Llp General1100.00%
Leydig Voit & Mayer Ltd10.00%

List of Epirium Bio Patents

Epirium Bio PatentsTitle
US11542298B2Hydroxysteroid Compounds, Their Intermediates, Process Of Preparation, Composition And Uses Thereof
US11273144B2Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders
US11154546B2Methods And Compositions For Treatment Of Mitochondrial Toxicity
US10898465B2Utility Of (+) Epicatechin And Their Analogs
US10618933B2Hydroxysteroid Compounds, Their Intermediates, Process Of Preparation, Composition And Uses Thereof
US10052316B2Methods And Compositions For Treatment Of Mitochondrial Toxicity
US9975869B2Analogues Of Epicatechin And Related Polyphenols
US9901564B2Compounds And Compositions For The Treatment Of Muscular Disorders
US9556140B2Approach For Synthesis Of Catechins
US9428482B2Process For Synthesis Of Polyphenols
US9187448B2Flavonoid Compounds
US20230250131A1Hydroxysteroid Compounds
US20230192638A1Polyphenols Derivatives
US20220401409A1Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders
EP2948437B1Approach For Synthesis Of Catechins
EP4228650A1Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof
CN113227067ACo-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
CN111989098ACompounds And Compositions For Treatment Of Muscular Disorders
WO2023009642A1Pyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using
WO2023009618A1Bicyclic Pgdh Inhibitors And Methods Of Making And Using
DE602014081026T2Process For The Synthesis Of Catechins
CA3195859A1Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof
CA3117466A1Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
CA3091892A1Compounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders
AU2021361071A1Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof
AU2019224003A1Compounds And Compositions For The Treatment Of Muscular Disorders
IL282571ACo-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
IL276786ACompounds And Compositions For The Treatment Of Muscular Disorders And Bone Disorders
AR126584A1Pyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using Them
TW202310836APyrrolo[2,3-B]Pyridine Pgdh Inhibitors And Methods Of Making And Using
US20210380535A1Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
US20210177801A1Utility Of (+) Epicatechin And Their Analogs
US20190262347A1Composition Comprising Combination Of Epicatechin And Anti-Cancer Compound
US20150376225A1Novel Compounds Of 11Beta-Hydroxy-Steroids For Use In Mitochondria Biogenesis And Diseases Associated With Mitochondrial Dysfunction Or Depletion
EP3755319A4Compounds And Compositions For The Treatment Of Muscular Disorders
EP3870571A1Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
WO2022082009A1Inhaled Formulations Of Pgdh Inhibitors And Methods Of Use Thereof
AU2019363595A1Co-Crystals Comprising Epicatechin And A Carboxy-N-Heterocyclic Co-Crystal Former
BR112021007684A2Cocrystal, Pharmaceutical Composition, Methods For Treatment Of A Disease Or Disorder That Would Benefit From Modification Of The Electron Transport Chain, To Reduce Triglyceride Levels, To Treat A Disease Or Disorder Selected From The Group Consisting Of A Dietabolic Syndrome, Type Ii, A Congenital Hyperlipidemia And Drug-Induced Hyperlipidemia, To Treat A Condition Related To Mitochondrial Dysfunction, To Improve Sports Performance, Endurance, Building Form Or Muscle Strength, Or To Facilitate Recovery From The Effects Of Training Or Competition, And To Treat Preventing Dystrophinopathy, Sarcoglycanopathy Or Dysferlinopathy, Process For Preparing A Co-Crystal, And, Use Of A Co-Crystal
BR112020016923A2A Method For Reversing Or Mitigating Injury, Or Bone Weakness Or Loss, Or For Avoiding Fractures In An Individual, And, Composition
AT1443865TProcess For The Synthesis Of Catechins

What are Epirium Bio key innovation segments?

What Technologies are Covered by Epirium Bio?

The chart below distributes patents filed by Epirium Bio in different countries on the basis of the technology protected in patents. It also represents the markets where Epirium Bio thinks it’s important to protect particular technology inventions.

R&D Focus: How has Epirium Bio search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Epirium Bio?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.